Revenue FY2025
$10.0M
Net Income
$(251.0M)
EPS (Basic)
$-1.37
Net Margin
-2588.2%
ROE
-1198.6%
Total Equity
$21.0M
Shares Out
358M
PRECIGEN, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 1 fund in our universe
FundPosition Value% of AUMQoQ ChgWeight
Patient Capital Management
Samantha McLemore
$108.5M
4.3%
+6.8%
Insider Transactions
Reading stored insider transactions…